Medical - Diagnostics/Research Stocks
The companies in this industry provide analysis and diagnostic services by examining body fluids and producing images of the body for medical professionals and patients. Demand correlates with the number of people receiving medical treatment. The profitability of individual companies depends on efficient operations and take advantage of the ability to draw business from a wide geographical area.
Share This Page
B
Industry Rank
This industry ranks #29 out of 123 stock categories.
B
Average POWR Rating
The average market cap-weighted POWR Rating for stocks in this industry is B (Buy).
| Rk | Symbol | Name | Last | Open | High | Low | 52WK Hi | 52WK Lo | Day Chg | YTD Chg | 12M Chg | Mkt Cap | 50D MA | ± 50D | 200D MA | ± 200D | POWR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc | 428.39 | 426.51 | 431.12 | 424.04 | 441.96 | 250.21 | 6.10 (1.44%) |
32.12% | 49.06% | 169.47B | 419.30 | 2.17% | 351.82 | 21.76% |
A Strong Buy |
| 2 | A | Agilent Technologies, Inc. | 99.51 | 98.64 | 99.73 | 98.12 | 103.66 | 61.13 | 1.82 (1.86%) |
17.19% | 30.27% | 30.68B | 97.98 | 1.56% | 85.93 | 15.80% |
A Strong Buy |
| 3 | BIO | Bio-Rad Laboratories, Inc. | 513.92 | 508.85 | 519.47 | 508.85 | 540.06 | 309.38 | 9.77 (1.94%) |
38.89% | 53.87% | 15.25B | 512.84 | 0.21% | 433.70 | 18.50% |
A Strong Buy |
| 4 | QGEN | Qiagen N.V. Common Shares | 51.51 | 52.45 | 52.51 | 51.44 | 52.86 | 25.04 | -0.41 (-0.79%) |
52.40% | 56.80% | 11.73B | 49.74 | 3.56% | 42.37 | 21.57% |
A Strong Buy |
| 5 | CRL | Charles River Laboratories International, Inc. | 223.42 | 219.54 | 224.30 | 219.09 | 228.86 | 95.58 | 6.65 (3.07%) |
46.26% | 68.47% | 11.10B | 212.34 | 5.22% | 170.68 | 30.90% |
A Strong Buy |
| 6 | IRTC | iRhythm Technologies, Inc. | 228.74 | 230.13 | 233.35 | 225.62 | 241.82 | 56.24 | 1.58 (0.70%) |
235.94% | 208.73% | 6.27B | 189.33 | 20.81% | 118.90 | 92.38% |
A Strong Buy |
| 7 | NVTA | Invitae Corporation | 43.90 | 45.24 | 46.17 | 43.23 | 46.17 | 7.41 | -0.77 (-1.72%) |
172.16% | 132.89% | 5.79B | 34.01 | 29.08% | 22.72 | 93.24% |
A Strong Buy |
| 8 | NTRA | Natera, Inc. | 70.05 | 70.16 | 70.97 | 68.56 | 71.08 | 16.87 | 1.43 (2.08%) |
107.93% | 117.88% | 5.60B | 58.40 | 19.96% | 42.76 | 63.81% |
A Strong Buy |
| 9 | NEOG | Neogen Corporation | 77.59 | 76.00 | 78.20 | 74.21 | 82.06 | 48.91 | 2.20 (2.92%) |
18.89% | 18.95% | 4.11B | 76.22 | 1.80% | 69.73 | 11.28% |
A Strong Buy |
| 10 | NSTG | NanoString Technologies, Inc. | 44.36 | 44.66 | 45.00 | 43.68 | 46.93 | 13.85 | 0.67 (1.53%) |
59.45% | 109.15% | 1.69B | 39.39 | 12.61% | 32.11 | 38.14% |
A Strong Buy |
| 11 | PACB | Pacific Biosciences of California, Inc. | 9.60 | 9.35 | 9.64 | 9.02 | 9.64 | 2.20 | 0.35 (3.78%) |
86.77% | 83.91% | 1.48B | 6.04 | 58.87% | 4.43 | 116.59% |
A Strong Buy |
| 12 | IQV | IQVIA Holdings, Inc. | 155.31 | 153.50 | 156.99 | 153.50 | 170.51 | 81.79 | 4.01 (2.65%) |
0.52% | 4.76% | 29.71B | 159.44 | -2.59% | 145.38 | 6.83% |
B Buy |
| 13 | LH | Laboratory Corporation of America Holdings | 184.07 | 183.05 | 186.22 | 183.05 | 206.74 | 98.02 | 3.08 (1.70%) |
8.81% | 11.27% | 17.93B | 185.79 | -0.93% | 170.82 | 7.76% |
B Buy |
| 14 | DGX | Quest Diagnostics Incorporated | 113.88 | 112.68 | 115.40 | 112.66 | 131.81 | 73.02 | 2.18 (1.95%) |
8.51% | 7.95% | 15.29B | 118.08 | -3.56% | 108.40 | 5.06% |
B Buy |
| 15 | EXAS | Exact Sciences Corporation | 99.70 | 98.72 | 100.90 | 96.55 | 105.56 | 35.25 | 2.00 (2.05%) |
7.81% | 8.37% | 14.97B | 84.50 | 17.98% | 82.99 | 20.14% |
B Buy |
| 16 | ICLR | ICON plc - Ordinary Shares | 186.04 | 184.61 | 186.86 | 177.54 | 199.83 | 104.28 | 2.90 (1.58%) |
8.02% | 26.31% | 9.98B | 185.67 | 0.20% | 167.10 | 11.33% |
B Buy |
| 17 | PRAH | PRA Health Sciences, Inc. | 99.15 | 98.50 | 99.74 | 96.86 | 113.32 | 58.67 | 1.86 (1.91%) |
-10.80% | 0.76% | 6.34B | 103.35 | -4.06% | 98.20 | 0.97% |
B Buy |
| 18 | NEO | NeoGenomics, Inc. | 36.16 | 36.25 | 36.63 | 35.84 | 41.03 | 18.52 | 0.34 (0.95%) |
23.62% | 89.12% | 3.99B | 37.61 | -3.85% | 31.39 | 15.21% |
B Buy |
| 19 | CDNA | CareDx, Inc. | 34.64 | 33.04 | 34.75 | 32.63 | 37.54 | 13.04 | 1.87 (5.71%) |
60.59% | 58.68% | 1.70B | 33.37 | 3.81% | 27.78 | 24.68% |
B Buy |
| 20 | HSKA | Heska Corporation | 100.44 | 99.67 | 101.66 | 99.37 | 110.90 | 50.00 | 1.82 (1.85%) |
4.69% | 44.73% | 948.56M | 100.32 | 0.12% | 89.21 | 12.59% |
B Buy |
| 21 | QTRX | Quanterix Corporation | 32.93 | 33.09 | 33.57 | 32.32 | 37.77 | 10.90 | 0.16 (0.49%) |
39.36% | 51.61% | 936.53M | 33.17 | -0.73% | 26.55 | 24.01% |
B Buy |
| 22 | FLGT | Fulgent Genetics, Inc. | 38.94 | 40.00 | 41.24 | 37.62 | 52.47 | 6.70 | -0.44 (-1.12%) |
201.86% | 280.65% | 861.16M | 33.92 | 14.81% | 19.64 | 98.27% |
B Buy |
| 23 | SMLR | Semler Scientific Inc. | 53.00 | 51.50 | 56.00 | 50.30 | 60.00 | 30.00 | 2.90 (5.79%) |
10.42% | 26.98% | 348.58M | 52.42 | 1.10% | 47.11 | 12.50% |
B Buy |
| 24 | QDEL | Quidel Corporation | 198.64 | 198.79 | 200.90 | 194.33 | 306.72 | 55.25 | 1.87 (0.95%) |
164.75% | 229.69% | 8.33B | 219.60 | -9.54% | 148.41 | 33.84% |
C Neutral |
| 25 | BRKR | Bruker Corporation | 39.49 | 39.48 | 40.03 | 39.32 | 54.49 | 30.78 | 0.33 (0.84%) |
-22.31% | -11.10% | 6.05B | 41.85 | -5.64% | 42.92 | -7.98% |
C Neutral |
| 26 | BEAT | BioTelemetry, Inc. | 44.85 | 44.72 | 45.57 | 44.62 | 55.85 | 27.35 | 0.82 (1.86%) |
-3.13% | 10.74% | 1.53B | 41.46 | 8.17% | 44.31 | 1.22% |
C Neutral |
| 27 | BRBR | BELLRING BRANDS, INC. | 19.86 | 19.34 | 20.00 | 19.03 | 24.03 | 13.56 | 1.14 (6.09%) |
-6.72% | 20.36% | 783.04M | 19.59 | 1.38% | 19.65 | 1.08% |
C Neutral |
| 28 | SRDX | Surmodics, Inc. | 38.97 | 38.81 | 39.95 | 38.81 | 49.00 | 22.06 | 0.63 (1.64%) |
-5.94% | -13.30% | 530.23M | 44.35 | -12.13% | 39.50 | -1.34% |
C Neutral |
| 29 | FLDM | Fluidigm Corporation | 7.24 | 7.18 | 7.45 | 7.01 | 12.45 | 1.17 | 0.17 (2.40%) |
108.05% | 53.72% | 516.33M | 7.25 | -0.07% | 4.46 | 62.23% |
C Neutral |
| 30 | HBIO | Harvard Bioscience, Inc. | 2.99 | 2.99 | 3.01 | 2.92 | 4.41 | 1.39 | 0.00 (0.00%) |
-1.97% | -0.66% | 116.44M | 3.35 | -10.72% | 2.93 | 2.21% |
C Neutral |
| 31 | BASI | Bioanalytical Systems, Inc. | 4.84 | 4.99 | 5.00 | 4.80 | 6.50 | 3.00 | -0.02 (-0.41%) |
-2.22% | 31.17% | 53.19M | 5.00 | -3.17% | 4.74 | 2.09% |
C Neutral |
| 32 | SYNH | Syneos Health, Inc. - | 53.39 | 52.61 | 54.48 | 52.47 | 74.25 | 30.02 | 1.81 (3.51%) |
-10.23% | 0.75% | 5.58B | 60.10 | -11.16% | 57.34 | -6.89% |
D Sell |
| 33 | MYGN | Myriad Genetics, Inc. | 12.66 | 12.66 | 12.86 | 12.51 | 35.29 | 9.24 | 0.22 (1.77%) |
-53.51% | -55.53% | 945.82M | 12.89 | -1.82% | 16.66 | -24.03% |
D Sell |
| 34 | LNTH | Lantheus Holdings, Inc. | 12.43 | 12.36 | 12.64 | 12.35 | 25.49 | 8.67 | 0.23 (1.89%) |
-39.40% | -50.91% | 830.49M | 13.50 | -7.95% | 14.72 | -15.57% |
D Sell |
| 35 | RDNT | RadNet, Inc. | 14.99 | 14.73 | 15.20 | 14.73 | 23.45 | 5.81 | 0.47 (3.24%) |
-26.16% | 5.34% | 773.11M | 15.77 | -4.94% | 16.55 | -9.45% |
D Sell |
| 36 | VIVO | Meridian Bioscience Inc. | 16.61 | 16.60 | 17.00 | 16.44 | 26.58 | 5.51 | 0.11 (0.67%) |
70.01% | 75.12% | 711.95M | 18.44 | -9.91% | 13.86 | 19.82% |
D Sell |
| 37 | AXDX | Accelerate Diagnostics, Inc. | 10.91 | 11.64 | 11.99 | 10.86 | 19.22 | 4.53 | -0.59 (-5.13%) |
-35.44% | -42.34% | 614.83M | 13.31 | -18.02% | 12.90 | -15.42% |
D Sell |
| 38 | CO | Global Cord Blood Corporation | 3.39 | 3.37 | 3.47 | 3.37 | 5.79 | 2.54 | 0.02 (0.59%) |
-32.20% | -28.78% | 412.06M | 3.51 | -3.50% | 3.65 | -7.12% |
D Sell |
| 39 | OXFD | Oxford Immunotec Global PLC - Ordinary Shares | 11.77 | 11.82 | 11.86 | 11.65 | 17.77 | 8.37 | 0.03 (0.26%) |
-29.10% | -29.61% | 305.50M | 13.33 | -11.68% | 13.33 | -11.73% |
D Sell |
| 40 | CNTG | CENTOGENE N.V. | 9.30 | 10.01 | 10.01 | 9.25 | 28.71 | 7.80 | -0.33 (-3.43%) |
-7.65% | -25.54% | 184.71M | 11.77 | -20.99% | 14.87 | -37.46% |
D Sell |
| 41 | LOGC | LogicBio Therapeutics, Inc. | 7.43 | 7.69 | 7.75 | 7.40 | 11.60 | 3.05 | 0.43 (6.14%) |
3.19% | -21.79% | 175.66M | 7.44 | -0.10% | 7.31 | 1.63% |
D Sell |
| 42 | VNRX | VolitionRX Limited | 3.32 | 3.13 | 3.33 | 3.04 | 6.20 | 2.22 | 0.28 (9.21%) |
-29.96% | -39.19% | 159.09M | 3.36 | -1.33% | 3.79 | -12.36% |
D Sell |
| 43 | XGN | EXAGEN INC. | 10.85 | 10.91 | 11.40 | 10.74 | 29.86 | 10.29 | 0.22 (2.07%) |
-57.28% | -25.17% | 137.14M | 13.28 | -18.30% | 15.91 | -31.82% |
D Sell |
| 44 | ENZ | Enzo Biochem, Inc. ($0.01 Par Value) | 2.14 | 2.16 | 2.21 | 2.13 | 4.85 | 1.56 | -0.01 (-0.47%) |
-18.63% | -41.85% | 102.49M | 2.34 | -8.55% | 2.48 | -13.76% |
D Sell |
| 45 | SENS | Senseonics Holdings, Inc. | 0.40 | 0.40 | 0.41 | 0.38 | 1.78 | 0.36 | 0.03 (7.90%) |
-56.33% | -59.59% | 97.55M | 0.46 | -12.11% | 0.67 | -40.58% |
D Sell |
| 46 | CEMI | Chembio Diagnostics, Inc. | 4.72 | 4.65 | 4.84 | 4.59 | 15.89 | 2.25 | 0.04 (0.96%) |
3.51% | -26.48% | 95.16M | 4.80 | -1.70% | 6.02 | -21.57% |
D Sell |
| 47 | OCX | OncoCyte Corporation | 1.37 | 1.32 | 1.39 | 1.31 | 3.51 | 1.15 | 0.06 (4.58%) |
-39.11% | -29.02% | 92.13M | 1.45 | -5.70% | 2.16 | -36.43% |
D Sell |
| 48 | CELC | Celcuity Inc. | 6.00 | 5.98 | 6.14 | 5.98 | 18.38 | 4.03 | 0.20 (3.45%) |
-43.61% | -64.69% | 61.52M | 5.59 | 7.42% | 7.53 | -20.32% |
D Sell |
| 49 | BIOC | Biocept, Inc. | 4.36 | 4.26 | 4.45 | 4.16 | 13.00 | 2.11 | 0.16 (3.81%) |
52.45% | -46.61% | 58.39M | 6.75 | -35.43% | 4.84 | -9.93% |
D Sell |
| 50 | ONVO | Organovo Holdings, Inc. | 6.85 | 6.60 | 7.32 | 6.59 | 18.60 | 3.87 | 0.46 (7.20%) |
-3.71% | 26.71% | 44.74M | 10.44 | -34.38% | 9.24 | -25.87% |
D Sell |
| 51 | GENE | Genetic Technologies Ltd representing 150 ordinary shares | 3.29 | 3.30 | 3.38 | 3.25 | 10.30 | 1.41 | 0.04 (1.23%) |
65.32% | 68.72% | 44.57M | 3.95 | -16.77% | 2.90 | 13.53% |
D Sell |
| 52 | OPGN | OpGen, Inc. | 2.20 | 2.16 | 2.28 | 2.09 | 8.33 | 0.92 | 0.14 (6.80%) |
94.69% | -69.61% | 43.56M | 2.26 | -2.74% | 2.10 | 4.99% |
D Sell |
| 53 | PMD | Psychemedics Corporation | 4.37 | 4.35 | 4.47 | 4.35 | 10.69 | 4.33 | 0.04 (0.92%) |
-51.28% | -51.71% | 24.15M | 4.77 | -8.48% | 6.44 | -32.11% |
D Sell |
| 54 | HTGM | HTG Molecular Diagnostics, Inc. | 0.33 | 0.31 | 0.34 | 0.31 | 0.99 | 0.27 | 0.01 (4.26%) |
-52.98% | -46.41% | 23.54M | 0.47 | -30.31% | 0.52 | -37.00% |
D Sell |
| 55 | CGIX | Cancer Genetics, Inc. | 4.12 | 3.82 | 4.14 | 3.80 | 10.39 | 1.92 | 0.30 (7.85%) |
-30.87% | 43.06% | 9.51M | 3.94 | 4.58% | 3.81 | 8.23% |
D Sell |
| NR | NRCIB | National Research Corporation | 53.01 | 51.95 | 53.37 | 50.38 | 58.16 | 40.27 | 4.97 (10.35%) |
-5.44% | 32.56% | 1.30B | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | VRML | Vermillion, Inc. | 4.00 | 3.91 | 4.25 | 3.65 | 5.78 | 0.35 | -0.33 (-7.62%) |
393.83% | 247.83% | 389.51M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
| NR | TROV | TrovaGene, Inc. | 1.19 | 1.19 | 1.19 | 1.16 | 3.46 | 0.70 | -0.01 (-0.83%) |
-4.03% | -64.90% | 13.10M | N/A | N/A% | N/A | N/A% |
NR Not Rated |
All price changes on this page include dividends and splits.